Vanta Bioscience

30.00
0.00
(0.00%)
Market Cap
18.90 Cr
EPS
-3.67
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
101.64
52 Week low
30.00
PB Ratio
1.25
Debt to Equity
3.61
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
713.75 28,765.30 60.28 3,579.20 9.66 510 17.58 34.75
555.55 13,320.10 34.84 2,665.90 12.77 337 11.03 34.64
117.60 2,583.10 - 32.80 49.09 -105 6.46 42.98
946.75 2,145.00 35.25 322.30 0.22 41 112.87 48.85
11.23 158.70 - 67.20 -65.97 -120 2,371.43 42.26
60.39 136.60 - 769.70 -22.39 -59 17.26 41.44
48.81 75.10 107.80 40.30 8.04 -1 120.00 56.21
17.50 24.20 30.45 80.00 -3.26 2 -80.00 36.86
30.00 18.90 - 9.80 40.00 -9 -380.00 28.79
Growth Rate
Revenue Growth
40.00 %
Net Income Growth
-17.31 %
Cash Flow Change
525.40 %
ROE
20.22 %
ROCE
-24.77 %
EBITDA Margin (Avg.)
-158.91 %

Quarterly Financial Results

Quarterly Financials
Dec 2021
Mar 2022
Dec 2022
Mar 2023
Revenue
0
5
3
1
Expenses
0
2
3
2
EBITDA
0
2
-1
-1
Operating Profit %
0 %
46 %
-20 %
-206 %
Depreciation
0
1
1
0
Interest
0
1
3
1
Profit Before Tax
0
1
-4
-2
Tax
0
0
-2
-0
Net Profit
0
0
-3
-1
EPS in ₹
0.00
0.11
-4.06
0.00

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
Total Assets
39
49
70
81
85
85
Fixed Assets
18
21
29
36
57
54
Current Assets
17
20
20
15
15
17
Capital Work in Progress
4
7
19
29
11
13
Investments
2
0
0
0
0
0
Other Assets
16
21
21
17
17
19
Total Liabilities
39
49
70
81
85
85
Current Liabilities
3
10
15
18
18
23
Non Current Liabilities
13
14
29
34
48
50
Total Equity
23
25
26
29
19
13
Reserve & Surplus
16
17
18
18
11
9
Share Capital
6
6
6
6
6
6

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
Net Cash Flow
3
-3
3
-2
-0
0
Investing Activities
-6
-8
-22
-17
-6
-3
Operating Activities
-1
2
7
5
-1
3
Financing Activities
10
2
18
10
6
1

Share Holding

% Holding
Mar 2021
Sept 2021
Mar 2022
Sept 2022
Mar 2023
Sept 2023
Mar 2024
Sept 2024
Promoter
69.11 %
69.00 %
69.00 %
69.36 %
69.36 %
69.36 %
69.36 %
69.36 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
26.39 %
26.41 %
26.35 %
26.56 %
26.77 %
26.77 %
25.97 %
26.55 %
Others
4.50 %
4.59 %
4.65 %
4.08 %
3.87 %
3.87 %
4.67 %
4.09 %
No of Share Holders
361
412
409
393
394
388
418
424

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Technical Indicators

RSI(14)
Neutral
28.79
ATR(14)
Less Volatile
3.59
STOCH(9,6)
Oversold
13.23
STOCH RSI(14)
Oversold
1.30
MACD(12,26)
Bearish
-0.59
ADX(14)
Strong Trend
30.90
UO(9)
Bearish
74.90
ROC(12)
Downtrend And Accelerating
-21.98
WillR(14)
Neutral
-26.70